Evidence map›Paper›PMID 25444520›Full record

ReviewSurvey of ophthalmology

Corneal lymphangiogenesis in herpetic stromal keratitis.

Paul J Park, Michael Chang, Nitin Garg, Jimmy Zhu, Jin-Hong Chang, Deepak Shukla

Open access · greenAbstract readReview
In one paragraph

Review in Survey of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Ocular Lymphatics in Health and Disease.Diagnostics (Basel, Switzerland) · 2026
    Review
  2. From defense to disease: the multifaceted role of lymphatics during infection.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Paul J ParkDepartment of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Michael ChangDepartment of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Nitin GargDepartment of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Jimmy ZhuDepartment of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA; Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Jin-Hong ChangDepartment of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA; Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Deepak ShuklaDepartment of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA; Department Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA. Electronic address: dshukla@uic.edu.
University of Illinois Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 1985 to 2025
$14.8M
Center for Clinical and Translational ScienceUL1TR000050 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AZAR, DIMITRI T, MERMELSTEIN, ROBIN J. · 2012 to 2014
$9.8M
Significance of heparan sulfate in HSV-1 spreadK02AI081869 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 2009 to 2013
$531k
Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenesR21EY021886 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHANG, JIN-HONG · 2011 to 2012
$438k
VEGFR2 Modulates Corneal Angiogenesis and LymphangiogenesisR21EY023691 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHANG, JIN-HONG · 2013 to 2014
$435k
Endostatin-derived Short Peptides in Corneal TransplantationI01BX002386 · VA · JESSE BROWN VA MEDICAL CENTER · PI CHANG, JIN-HONG · 2014 to 2017
–
BLRD VA I01 BX002386NCATS NIH HHS UL1 TR000050NCATS NIH HHS UL1TR000050NEI NIH HHS EY01792NEI NIH HHS EY021886NEI NIH HHS EY023691NEI NIH HHS P30 EY001792NEI NIH HHS R21 EY021886NEI NIH HHS R21 EY023691NIAID NIH HHS AI081869NIAID NIH HHS K02 AI081869
6 · The paper itself

Abstract

Corneal lymphangiogenesis is the extension of lymphatic vessels into the normally alymphatic cornea, a process that compromises the cornea's immune-privileged state and facilitates herpetic stromal keratitis (HSK). HSK results most commonly from infection by herpes simplex virus-1 (HSV-1) and is characterized by immune- and inflammation-mediated damage to the deep layers of the cornea. Current research demonstrates the potential of anti-lymphangiogenic therapy to decrease and prevent herpes-induced lymphangiogenesis.

Indexed as

AnimalsCorneaCorneal StromaDisease Models, AnimalHumansKeratitis, HerpeticLymphangiogenesisLymphatic Vesselscorneaherpes simplex virus-1lymphangiogenesisneovascularizationvascular endothelial growth factor (VEGF)

Identifiers

PMID25444520
PMCPMC4262646
OpenAlexW2154134816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.